These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22105492)

  • 1. Assessment of risk factors for Korean children with Kawasaki disease.
    Kim JJ; Hong YM; Yun SW; Han MK; Lee KY; Song MS; Lee HD; Kim DS; Sohn S; Ha KS; Hong SJ; Kim KJ; Park IS; Jang GY; Lee JK;
    Pediatr Cardiol; 2012 Apr; 33(4):513-20. PubMed ID: 22105492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H; Cai J; Zhang R; Shuai S; Tang M; Ju R; Hu Y; Zuo T; Yang Y
    J Int Med Res; 2024 May; 52(5):3000605241252115. PubMed ID: 38713460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S; Kimura M; Ishikawa T; Ohzeki T
    Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients.
    Wang Z; Xu Y; Zhou H; Wang Y; Li W; Lu Z; Jiang Z; Gu X; Zheng H; Zeng L; Huang P; Zhang L; Gu X
    Cardiovasc Ther; 2020; 2020():3568608. PubMed ID: 32256707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children.
    Kim HE; Kim JJ; Han MK; Lee KY; Song MS; Lee HD; Kim DS; Yu JJ; Park IS; Yun SW; Hong YM; Jang GY; Lee JK;
    Pediatr Cardiol; 2012 Dec; 33(8):1259-63. PubMed ID: 22450355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Ahn JG; Bae Y; Shin D; Nam J; Kim KY; Kim DS
    Rheumatology (Oxford); 2019 May; 58(5):770-775. PubMed ID: 30535242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF
    Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
    Kibata T; Suzuki Y; Hasegawa S; Matsushige T; Kusuda T; Hoshide M; Takahashi K; Okada S; Wakiguchi H; Moriwake T; Uchida M; Ohbuchi N; Iwai T; Hasegawa M; Ichihara K; Yashiro M; Makino N; Nakamura Y; Ohga S
    Int J Cardiol; 2016 Jul; 214():209-15. PubMed ID: 27070994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.
    Mamtani M; Matsubara T; Shimizu C; Furukawa S; Akagi T; Onouchi Y; Hata A; Fujino A; He W; Ahuja SK; Burns JC
    PLoS One; 2010 Jul; 5(7):e11458. PubMed ID: 20628649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
    Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
    Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
    Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of tryptophan hydroxylase 2 (TPH2) gene polymorphisms in susceptibility to coronary artery lesions in Korean children with Kawasaki disease.
    Park SW; Ban JY; Yoon KL; Kim HJ; Chung JY; Yi JW; Lee BJ; Chung JH
    Eur J Pediatr; 2010 Apr; 169(4):457-61. PubMed ID: 19763617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease.
    Weng KP; Hsieh KS; Hwang YT; Huang SH; Lai TJ; Yuh YS; Hou YY; Lin CC; Huang SC; Chang CK; Lin MW; Ger LP
    Circ J; 2010 May; 74(5):983-9. PubMed ID: 20339193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.